# Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)

> **NCT05494788** · PHASE2 · COMPLETED · sponsor: **Cardiol Therapeutics Inc.** · enrollment: 27 (actual)

## Conditions studied

- Recurrent Pericarditis

## Interventions

- **DRUG:** CardiolRx

## Key facts

- **NCT ID:** NCT05494788
- **Lead sponsor:** Cardiol Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-09
- **Primary completion:** 2024-06-15
- **Final completion:** 2024-09-06
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2025-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05494788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05494788, "Impact of CardiolRxTM on Recurrent Pericarditis (MAvERIC-Pilot)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05494788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*